Article
A retrospective cohort study of isoniazid-resistant tuberculosis treatment outcomes and isoniazid resistance-associated mutations in eastern China from 2013 to 2018.
Journal of global antimicrobial resistance - 1 Sept 2020
Shao Yan, Li Yishu, Song Honghuan, Li Guoli, Li Yan, Zhu Limei, Lu Wei, Chen Cheng
Abstract excerpt
OBJECTIVES: The current situation of isoniazid-resistant, rifampicin-susceptible tuberculosis (Hr-TB) and associated genetic factors is not clear in China. METHODS: A retrospective cohort study was conducted from 2013 to 2018 in Jiangsu Province, China. Phenotypic Hr-TB were identified by drug susceptibility testing on Lowenstein-Jensen medium and using a Mycobacterium Growth Indicator Tube 960 (MGIT 960) system,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
